Information for patients
Allergy UK is an organisation that has produced useful information for patients with allergies, please follow this link to access this.
Anaphylaxis Campaign is another very useful source of information; please follow this link to access this.
For appointment enquiries please contact central appointments on 0300 555 0103. If you feel that your condition has changed or if your case has become more urgent please discuss with your GP. We will not deal with these requests unless you GP has reviewed your case and given the reasons why it is more urgent. Patients should only contact the department if they are already under our service and they feel their allergy problem requires urgent attention. The telephone numbers are 0117 4148392 or 0117 4148393
Our services will flex according to the situation in the hospital and consultations may be performed by telephone or video call. We know that some patients will have seen delays in their treatment as a result of the impact of COVID-19 on our services, and we would like to apologise for any inconvenience caused.
Please access the government coronavirus website for general information and recommendations on coronavirus.
INFORMATION FOR GPs – Clinical Allergy Service
We run regular Adult Allergy (and Immunology/Immunodeficiency) clinics on Tuesday mornings, Thursday afternoons, and all day Friday seeing patients referred (see Patient Referral Pathways) to our service with suspected or confirmed allergic disease. Criteria and advice for whom to refer can be found on the Remedy website.
Patient referrals are accepted via the NHS e-Referral Service (e-RS) and an Advice and Guidance service also operates via the same channel. Please ensure Adult Allergy is selected for both of these services (not Immunology).
We see patients in our Adult Allergy service with the following conditions:
- Allergic rhinoconjunctivitis
- Bee or wasp venom allergy
- Drug and anaesthetic allergy. Referral for anaesthetic allergy investigation will only be accepted from the relevant anaesthetic department – see below
- Food allergy
- Urticaria and/or angioedema
- C1 esterase inhibitor deficiency (Hereditary Angioedema)
Please include as much detail about the clinical reaction/issue, relevant hospital discharge summaries, past medical history, past treatments (if relevant) and current medications. Referrals will not be accepted with inadequate information. For suspected General Anaesthetic Allergy Referrals please email firstname.lastname@example.org and a referral pro-forma will be supplied to you.
We also offer a dedicated ‘Adult Allergy COVID-19 Vaccine Advice and Guidance’ service that can be accessed via eRS by General Practitioners. Patients who have had a suspected allergic reaction following their first COVID-19 vaccination, or who have a previous history or allergy that indicates the possibility of a high risk of a reaction to the COVID-19 vaccine can be referred by their GP for advice. Following review then GPs may be invited to refer to the ‘Adult Allergy COVID-19 Vaccine’ service (by invitation only). Please see here for more information and please check the most up to date information about COVID19 vaccine reactions in the Green Book (chapter 14a) as well as the BSACI FAQ sheet before proceeding. For up to date information on COVID-19 vaccine allergy you can also visit the Anaphylaxis UK website. For suspected non-allergic reactions to this vaccine other specialties or the South West Immunization Regional Clinical Advice and Response Service may be better suited to offer advice.
Please note we do not see patients for:
- Patch testing (e.g. for eczema, contact hypersensitivity) – please refer to Dermatology instead.
- Lactose or food “intolerance” as we do not have expertise in these conditions.
- Myalgic encephalomyelitis (ME), chronic fatigue, or fibromyalgia as we do not have expertise in these conditions.
- Mast cell activation disorders as we do not have expertise in the management of these conditions.
Our service also performs:
- Sublingual and subcutaneous desensitisation (COVID19 permitting)
- Omalizumab injections for chronic spontaneous urticaria
- Drug and food allergy challenges
- Drug desensitisation
Page updated 25/02/2022